Nosocomial infections among coronavirus patients (search done on 31 March 2020)

Added September 1, 2020

Citation: Zhou Q, Gao Y, Wang X et al. Nosocomial Infections Among Patients with COVID-19, SARS and MERS: A Rapid Review and Meta-Analysis. Annals of Translational Medicine 2020 May;8(10):629.

What is this? Many patients with COVID-19 will need to attend hospitals, potentially increasing the risk of hospital acquired infections (also known as nosocomial infections).

In this rapid review, the authors searched for studies reporting the proportion of cases of COVID-19, SARS and MERS who were infected in health facilities and about infections among medical staff and outbreaks in hospitals. They did not restrict their searches by date or language and did the search on 31 March 2020. They included 40 studies, which were from Canada (2 studies), China (23), Hong Kong (2), Jordan (1), Saudi Arabia (7), South Korea (3) and Singapore (1), with 1 not stated.

What was found: At the time of this review, the included studies showed that the proportion of nosocomial infections was approximately 44% in early outbreaks of COVID-19.

At the time of this review, the included studies showed that one third of patients with nosocomial COVID-19 infections were medical staff. Nurses and doctors were the most affected among the infected medical staff.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.